![]() |
市场调查报告书
商品编码
1700029
2032 年外科密封剂和黏合剂预测:按产品类型、剂型、适应症、应用、最终用户、地区进行的全球分析Surgical Sealants and Adhesives Market Forecasts to 2032 - Global Analysis By Product Type (Surgical Sealants, Surgical Adhesives and Other Product Types), Form, Indication, Application, End User and By Geography |
根据 Stratistics MRC 的数据,全球手术密封剂和黏合剂市场预计在 2025 年达到 36.1 亿美元,预计到 2032 年将达到 81.5 亿美元,预测期内的复合年增长率为 12.3%。
手术密封剂和黏合剂是用于在手术过程中黏合或密封组织的医疗物质。它可以加强组织表面之间的结合,促进癒合,减少出血并有助于伤口缝合。这些材料由天然或合成成分製成,用途广泛,可用于重组、消化器官系统和心血管手术。黏合剂可以在组织之间建立长期连接,而密封剂通常充当阻止液体洩漏的屏障。
《英国外科杂誌》的一份报告估计,2020 年 5 月,印度每週约有 48,728 例手术被取消,导致 12 週内约有 585,000 例手术被取消。
外科手术增加
癌症和心血管疾病等需要频繁手术的慢性疾病的盛行率上升是导致这一增长的主要原因。此外,世界人口老化也增加了需求,因为人们更容易患上需要手术治疗的疾病。随着微创手术技术的进步,密封剂和黏合剂的使用增加,以改善恢復并减少併发症。此外,新兴经济体外科治疗机会的改善和医疗支出的增加也在推动市场的发展。
尖端产品高成本
复杂的配方、严格的品管和法规遵循要求使得这些产品的製造成本高昂,尤其是那些使用生物相容性材料和新技术的产品。这种尖端医疗设备的前期成本很高,因此通常无法广泛普及,尤其是在预算有限的地区或规模较小的医疗保健提供者。这些考虑可能会迫使医院和诊所使用缝线和钉书钉等传统伤口缝合技术,因为它们价格低廉。此外,高价格可能会阻碍人们使用现代、更有效率的密封剂和黏合剂,从而阻碍市场发展,尤其是在医疗资源有限的新兴国家。
创伤治疗产品需求不断增加
随着世界人口老化以及慢性病和外科手术的盛行率上升,对先进的创伤治疗疗法的需求也日益增加。手术密封剂和黏合剂对于加速癒合、降低感染风险和减少术后疤痕至关重要。这些产品在复杂的手术中特别有用,例如整形外科和心血管手术,因为组织密封对于癒合至关重要。此外,人们越来越关注改善患者治疗效果和降低医疗成本,从而更加重视正确的伤口管理,这推动了对手术密封剂和黏合剂的需求。
复杂的应用和培训要求
根据手术类型和所涉及的组织,这些产品通常需要精确的应用中,以确保良好的黏附、止血和组织密封。外科医生和医务相关人员需要接受专门培训才能熟练这些技术,这使得实施这些技术既费时又昂贵。此外,不正确的给药可能导致感染疾病和创伤治疗不良等併发症,影响患者的预后。此外,继续教育和技术发展的需求以及产品配方的变化限制了某些地区的市场发展,并使广泛采用更加困难。
COVID-19 疫情对手术密封剂和黏合剂市场产生了重大影响。为了优先考虑紧急护理并节省资源,全球范围内的选择性手术已被推迟或取消。这导致这些产品的需求暂时下降。然而,随着医疗保健系统的适应和手术量在关闭后恢復,市场逐渐復苏。此次疫情也凸显了密封剂和黏合剂等先进外科解决方案在改善病患预后、减少住院时间、促进长期成长前景的重要性。
预计手术密封剂市场在预测期内将占据最大份额
预计在预测期内,手术密封剂部分将占据最大的市场占有率。这是因为慢性病增加和人口老化导致外科手术数量的增加,从而推动了需求。此外,微创手术的进步以及有效止血和组织封闭的需求也做出了巨大贡献。技术创新,特别是生物相容性材料和仿生密封剂,将进一步扩大应用和市场成长。此外,减少术后併发症和缩短患者康復时间的重点将推动这些产品的采用。
预计在预测期内,医院部门的复合年增长率最高。
预计医院部门在预测期内将出现最高的成长率。这是因为手术过程中高效可靠的止血和组织封闭至关重要。人口老化和慢性病手术数量的增加正在推动需求。由于医院优先考虑减少术后併发症和缩短患者康復时间,因此他们越来越多地采用先进的密封剂。此外,医院参与临床试验,并且通常是新手术技术的早期采用者,从而影响市场趋势和产品开发。
预计亚太地区将在预测期内占据最大的市场占有率。这是由于人口老化迅速、慢性病盛行率上升以及外科手术数量的增加。医疗基础设施的扩大和可支配收入的增加正在改善人们获得先进医疗服务的机会。医疗旅游和对微创手术的日益关注进一步刺激了需求。此外,人们对先进创伤护理和止血解决方案的认识不断提高,推动了市场的成长。
由于微创手术的广泛采用,预计北美在预测期内将呈现最高的复合年增长率。人口老化和慢性病的增加推动了手术需求的增加。严格的监管标准确保产品的高品质和创新性。强大的研发投入和技术进步,尤其是在生物相容性材料方面,将推动市场成长。报销政策和减少住院时间的关注也导致了密封剂和黏合剂的使用增加。
According to Stratistics MRC, the Global Surgical Sealants and Adhesives Market is accounted for $3.61 billion in 2025 and is expected to reach $8.15 billion by 2032 growing at a CAGR of 12.3% during the forecast period. Surgical sealants and adhesives are medical substances used to bind or seal tissues during surgical procedures. They strengthen the link between tissue surfaces, promoting healing, reducing bleeding, and assisting in wound closure. These materials, which can be made of natural or synthetic components, are versatile and can be used in reconstructive, gastrointestinal, and cardiovascular procedures. While adhesives offer long-lasting tissue connection, sealants frequently serve as barriers to stop fluid leaks.
According to the British Journal of Surgery report, in May 2020, around 48,728 surgical procedures per week were canceled in India, estimating about 585,000 surgical procedures for 12 weeks.
Increasing surgical procedures
The rising incidence of chronic illnesses like cancer and cardiovascular conditions, which frequently call for surgical procedures, is the main cause of this increase. Furthermore, the aging of the world's population increases demand since it makes people more susceptible to illnesses that require surgery. The usage of sealants and adhesives has increased due to advancements in less invasive surgical methods, as they improve recovery and lower complications. Additionally, the market is growing as a result of enhanced access to surgical treatment and increased healthcare spending in emerging economies.
High cost of advanced products
Complex formulations, strict quality controls, and regulatory compliance requirements can make manufacturing these items costly, particularly those that use biocompatible materials or novel technology. These cutting-edge devices' high initial costs frequently prevent them from being widely available, especially in areas with tight budgets or for smaller healthcare practitioners. Due to the lower cost of traditional wound closure techniques like sutures or staples, this consideration may force hospitals and clinics to use them. Furthermore, the high price may discourage the broad use of more recent, efficient sealants and adhesives, which would hinder market expansion, especially in developing nations with limited healthcare resources.
Rising demand for wound healing products
Advanced wound healing treatments are becoming more and more necessary as the world's population ages and the prevalence of chronic illnesses and surgical procedures rises. Surgical adhesives and sealants are essential for encouraging quicker healing, lowering the risk of infection, and decreasing post-operative scarring. These products are particularly helpful in complicated surgeries where tissue sealing is essential for healing, like orthopedic and cardiovascular treatments. Additionally, there is a greater focus on proper wound management as a result of the growing emphasis on improving patient outcomes and lowering healthcare costs, which is driving up demand for surgical sealants and adhesives.
Complex application and training requirements
Depending on the type of surgery and tissue involved, these products frequently require precise application procedures to guarantee good adhesion, hemostasis, and tissue sealing. Adoption takes longer and costs more since surgeons and medical personnel need specific training to become proficient in these techniques. Furthermore, incorrect administration might affect patient outcomes by causing complications like infections or insufficient wound healing. Their widespread usage is made more difficult by the requirement for ongoing education and skill development as well as the variation in product compositions, which restricts market expansion in particular areas.
The COVID-19 pandemic significantly impacted the surgical sealants and adhesives market, as elective surgeries were postponed or canceled globally to prioritize emergency care and conserve resources. This led to a temporary decline in demand for these products. However, the market witnessed a gradual recovery as healthcare systems adapted and surgical volumes rebounded post-lockdowns. The pandemic also highlighted the importance of advanced surgical solutions, including sealants and adhesives, in improving patient outcomes and reducing hospital stays, driving long-term growth prospects.
The surgical sealants segment is expected to be the largest during the forecast period
The surgical sealants segment is expected to account for the largest market share during the forecast period, due to the increasing volume of surgical procedures, driven by a rise in chronic diseases and an aging population, fuels demand. Additionally, advancements in minimally invasive surgeries and the need for effective hemostasis and tissue sealing contribute significantly. Technological innovations, particularly in biocompatible materials and biomimetic sealants, further expand applications and market growth. Furthermore, the focus on reducing post-surgical complications and improving patient recovery times enhances the adoption of these products.
The hospitals segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the hospitals segment is predicted to witness the highest growth rate, due to their need for efficient, reliable hemostasis and tissue sealing during surgeries is paramount. Increased surgical volumes due to aging populations and chronic diseases drive demand. Hospitals prioritize minimizing post-operative complications and reducing patient recovery times, leading to greater adoption of advanced sealants. Furthermore, hospitals often participate in clinical trials and are early adopters of new surgical technologies, influencing market trends and product development.
During the forecast period, the Asia Pacific region is expected to hold the largest market share, driven by rapidly growing aging population and rising prevalence of chronic diseases, increasing surgical procedure volumes. Expanding healthcare infrastructure and rising disposable incomes improve access to advanced medical treatments. Medical tourism and a growing focus on minimally invasive surgeries further accelerate demand. Additionally, increasing awareness about advanced wound care and hemostasis solutions boosts market growth.
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, due to high adoption rates of minimally invasive surgeries. An aging population and rising chronic disease prevalence increase surgical demand. Stringent regulatory standards ensure high-quality, innovative products. Strong R&D investments and technological advancements, particularly in biocompatible materials, propel market growth. Reimbursement policies and a focus on reducing hospital stays also contribute to increased sealant and adhesive usage.
Key players in the market
Some of the key players in Surgical Sealants and Adhesives Market include 3M, Johnson & Johnson, Baxter International, CryoLife, Integra LifeSciences Corporation, Medtronic, Sealantis Ltd., Molnlycke Health Care, Globus Medical, Smith & Nephew, Tissuemed, Vermillion Inc., Asahi Kasei Corporation, TCL Surgical, Stryker Corporation, and Braun Melsungen AG.
In February 2025, Johnson & Johnson MedTech, an emerging leader in neurovascular care, announced today the launch of the CEREGLIDE(TM) 92 Catheter System, a next-generation .092" catheter with the INNERGLIDE(TM) 9 delivery aid, indicated for use in facilitating the insertion and guidance of interventional devices in the neurovascular system.
In December 2024, 3M and US Conec Ltd. announced a strategic licensing agreement for 3M(TM) Expanded Beam Optical Interconnect technology, a solution to meet the performance and scalability needs of next-generation data centers and advanced network architectures. The collaboration combines advanced optical technology from 3M with US Conec's expertise in high-density connectivity systems, expanded beam optics, and precision manufacturing.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.